SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matria Healthcare (MATR) -- Ignore unavailable to you. Want to Upgrade?


To: GREATMOOD who wrote (76)11/16/1997 4:51:00 PM
From: GREATMOOD  Read Replies (1) | Respond to of 220
 
To All:

H.D. BROUS & CO. formally initiated coverage of Matria Healthcare with an ACCUMULATE rating, and a twelve month price target of $12.00

The Matria story is just starting to get out!

Because of the recent substantial restructuring, IMHO this company is a mean lean fighting machine whose potential new top-line revenues will go directly to bottom line profits! In addition, Matria's management team has expressed a real interest in initiating a significant SHARE BUYBACK PROGRAM!

I think we have a company here that has very substantial upside potential, with very limited downside risk.

Good luck to all,

GM